Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer

Cancer Letters

Volumn 273, Issue 1, 2009, Pages 55-61

  Boccia, Stefania ^a   Boffetta, Paolo ^b   Brennan, Paul ^b   Ricciardi, Gualtiero ^a   Gianfagna, Francesco ^a   Matsuo, Keitaro ^c   Duijn, Cornelia M van ^d   Hung, Rayjean J ^b,e  

^a CATHOLIC UNIVERSITY   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Genetic susceptibility; Head and neck cancer; Lung cancer; Meta analysis; Methylenetetrahydrofolate reductase (MTHFR)

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIETARY INTAKE; DNA POLYMORPHISM; GENETIC VARIABILITY; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; LUNG CANCER; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 56349130046     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.026     Document Type: Article

References (40)

1. Choi S.W., and Mason J.B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130 (2000) 129-132
2. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 3290-3295
3. Duthie S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 55 (1999) 578-592
4. Parle-McDermott A., Mills J.L., Molloy A.M., Carroll N., Kirke P.N., Cox C., Conley M.R., Pangilinan F., Brody L.C., and Scott J.N. The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol. Genet. Metab. 88 (2006) 290-294
5. Friedman G., Goldschmidt N., Friedlander Y., Ben-Yehuda A., Selhub J., Babaey S., Mendel M., Kidron M., and Bar-On H. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J. Nutr. 129 (1999) 1656-1661
6. Shi Q., Zhang Z., Li G., Pillow P.C., Hernandez L.M., Spitz M.R., and Wei Q. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1477-1484
7. Hung R.J., Hashibe M., McKay J., Gaborieau V., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates I., Foretova L., Janout V., Bencko V., Chabrier A., Moullan N., Canzian F., Hall J., Boffetta P., and Brennan P. Folate related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 28 (2007) 1334-1340
8. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G., den Heijer M., Kluijtmans L.A., van den Heuve L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
9. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64 (1998) 169-172
10. Lievers K.J., Boers G.H., Verhoef P., den Heijer M., Kluijtmans L.A., van der Put N.M., Trijbels F.J., and Blom H.J. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J. Mol. Med. 79 (2001) 522-528
11. Bailey L.B. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C -->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133 (2003) 3748S-3753S
12. Vainio, F. Bianchini (Eds), IARC Handbooks of Cancer Prevention, vol. 8, Fruit and Vegetables, IARC Press, Lyon, 2003, pp. 1-376.
13. Kane M.A. The role of folates in squamous cell carcinoma of the head and neck. Cancer Detect. Prev. 29 (2005) 46-53
14. Cho E., Hunter D.J., Spiegelman D., Albanes D., Beeson W.L., van den Brandt P.A., Colditz G.A., Feskanich D., Folsom A.R., Fraser G.E., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Graham S., Miller A.B., Rohan T.E., Sellers T.A., Virtamo J., Willett W.C., and Smith-Warner S.A. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int. J. Cancer 118 (2006) 970-978
15. IARC Working Group on the evaluation of carcinogenic risks to humans schistosomes, liver flukes and Helicobacter pylori, IARC Monogr. Eval. Carcinog. Risks Hum. 61 (1994) 1-241.
16. Jatoi A., Daly B.D., Kramer G., and Mason J.B. Folate status among patients with non-small cell lung cancer: a case-control study. J. Surg. Oncol. 77 (2001) 247-252
17. Vineis P., Veglia F., Garte S., Malaveille C., Matullo G., Dunning A., Peluso M., Airoldi L., Overvad K., Raaschou-Nielsen O., Clavel-Chapelon F., Linseisen J.P., Kaaks R., Boeing H., Trichopoulou A., Palli D., Crosignani P., Tumino R., Panico S., Bueno-De-Mesquita H.B., Peeters P.H., Lund E., Gonzalez C.A., Martinez C., Dorronsoro M., Barricarte A., Navarro C., Quiros J.R., Berglund G., Jarvholm B., Key T.J., Saracci R., Riboli E., and Autrup H. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann. Oncol. 18 (2007) 1230-1242
18. Suzuki T., Matsuo K., Hiraki A., Saito T., Sato S., Yatabe Y., Mitsudomi T., Hida T., Ueda R., and Tajima K. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis 28 (2007) 1718-1725
19. Zhang X.M., Miao X.P., Tan W., Qu S.N., Sun T., Zhou Y.F., and Lin D.X. Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27 (2005) 700-703
20. Shen M., Rothman N., Berndt S.I., He X., Yeager M., Welch R., Chanock S., Caporaso N., and Lan Q. Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 49 (2005) 299-309
21. Jeng Y.L., Wu M.H., Huang H.B., Lin W.Y., You S.L., Chu T.Y., Chen C.J., and Sun C.A. The methylenetetrahydrofolate reductase 677C -->T polymorphism and lung cancer risk in a Chinese population. Anticancer Res. 23 (2003) 5149-5152
22. Siemianowicz K., Gminski J., Garczorz W., Slabiak N., Goss M., Machalski M., and Magiera-Molendowska H. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol. Rep. 10 (2003) 1341-1344
23. Heijmans B.T., Boer J.M., Suchiman H.E., Cornelisse C.J., Westendorp R.G., Kromhout D., Feskens E.J., and Slagboom P.E. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 63 (2003) 1249-1253
24. Shen H., Spitz M.R., Wang L.E., Hong W.K., and Wie Q. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 397-401
25. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., and Kelsey K.T. Global DNA methylation levels in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 108-114
26. Reljic A., Simundic A.M., Topic E., Nikolac N., Justinic D., and Stefanovic M. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin. Biochem. 40 (2007) 981-985
27. Suzuki T., Matsuo K., Hasegawa Y., Hiraki A., Wakai K., Hirose K., Saito T., Sato S., Ueda R., and Tajima K. One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci. 98 (2007) 1439-1446
28. Vairaktaris E., Yapijakis C., Kessler P., Vylliotis A., Ries J., Wiltfang J., Vassiliou S., Derka S., and Neukam F.W. Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J. Cancer Res. Clin. Oncol. 132 (2006) 219-222
29. Capaccio P., Ottaviani F., Cuccarini V., Cenzuales S., Cesana B.M., and Pignataro L. Association between methylenetetrahydrofolate reductase polymorphisms alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J. Laryngol. Otol. 119 (2005) 371-376
30. Neumann A.S., Lyons H.J., Shen H., Liu Z., Shi Q., Sturgis E.M., Shete S., Spitz M.R., El-Naggar A., Hong W.K., and Wei Q. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int. J. Cancer 115 (2005) 131-136
31. Kureshi N., Ghaffar S., Siddiqui S., Salahuddin I., and Frossard P.M. Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene. ORL J. Otorhinolaryngol. Relat. Spec. 66 (2004) 241-245
32. Weinstein S.J., Gridley G., Harty L.C., Diehl S.R., Brown L.M., Winn D.M., Bravo-Otero E., and Hayes R.B. Folate intake serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J. Nutr. 132 (2002) 762-767
33. Gemignani F., Landi S., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Gaborieau V., Gioia-Patricola L., Bellini I., Barale R., Canzian F., Hall J., Boffetta P., Hung R.J., and Brennan P. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28 (2007) 1287-1293
34. Mao R., Fan Y., Jin Y., Bai J., and Fu S. Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J. Hum. Genet. 53 (2008) 340-348
35. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
36. Deeks J.J., Altman D.G., and Bradburn M.J. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic Reviews in Health Care - Meta-analysis in Context (2005), BMJ Books, London 285-312
37. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
38. Ioannidis J.P., and Trikalinos T.A. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 176 (2007) 1091-1096
39. Malinow M.R., Duell P.B., Hess D.L., Anderson P.H., Kruger W.D., Phillipson B.E., Gluckman R.A., Block P.C., and Upson B.M. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med. 338 (1998) 1009-1015
40. Boccia S., Hung R., Ricciardi G., Gianfagna F., Ebert M.P., Fang J.Y., Gao C.M., Götze T., Graziano F., Lacasaña-Navarro M., Lin D., López-Carrillo L., et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am. J. Epidemiol. 167 (2008) 505-516